SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo:4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today that during the Japan Exchange Group’s (“JPX”) regularly scheduled press event on June 21, 2016 (Japan time), it was reported that Japan Exchange Regulation (a subsidiary of JPX) is conducting an inquiry into trades of Acucela shares
Status: Not yet recruiting,
Condition Summary: Dry Eye Syndromes; Keratoconjunctivitis Sicca
Topography-guided transepithelial surface ablation improved vision and reduced moderate to high astigmatism, according to a study.The retrospective study included 206 eyes; 153 eyes had myopic astigmatism and 53 eyes had mixed astigmatism.
ANN ARBOR, Mich.–(BUSINESS WIRE)–RetroSense Therapeutics LLC, a privately-held biopharmaceutical company, today announced that the MIT Technology Review has selected RetroSense as one of the 50 Smartest Companies in 2016.
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is celebrating National Sunglasses Day on June 27 by offering customers 25% off their entire purchase and free shipping for one day only on all products on its fostergrant.com website. The very first pair of Foster Grant sunglasses in the United States sold on the Atlantic City Boardwalk more than 85 years ago. Since 1929, Foster Grant has been a leader in sunglass style and innovation. The brand’s de
The FDA has accepted the new drug application for AC-170 to treat ocular itching associated with allergic conjunctivitis, according to a press release from Nicox. The FDA granted priority review and assigned a Prescription Drug User Fee Act goal date o…